NIH Innovation, CURES Act
Schedules
TAFS: 075-5628 /X - NIH Innovation, CURES Act
| Previously Approved (Iteration 2) | Current OMB Action (Iteration 3) | |||||
|---|---|---|---|---|---|---|
| Line # | Split | Description | Amount | Footnotes | Amount | Footnotes |
| 1000 | DA | Discretionary Actual - Unob Bal: Brought forward, October 1 | $75,944,831.00 | See footnotes below | $75,944,831.00 | See footnotes below |
| Footnotes for line 1000 (DA) (Previous): | B1: Pursuant to P. L. 116-260 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. | |||||
| Footnotes for line 1000 (DA) (Current): | B1: Pursuant to P. L. 116-260 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. | |||||
| 1021 | Unob Bal: Recov of prior year unpaid obligations | Line added | $1,485.00 | |||
| 1000 | DE | Discretionary Expected - Unob Bal: Brought forward, October 1 | Line removed | |||
| 1061 | Unob Bal: Antic recov of prior year unpd/pd obl | $5,000,000.00 | $4,998,515.00 | |||
| 1101 | BA: Disc: Appropriation (special or trust) | $404,000,000.00 | See footnotes below | $496,000,000.00 | See footnotes below | |
| Footnotes for line 1101 (Previous): | B2: Pursuant to PL 114-255, section 1001, FY 2021 NIH CURES Act innovation projects are funded in the amount of $404,000,000 to remain available until expended. | |||||
| Footnotes for line 1101 (Current): | B2: Pursuant to PL 114-255, section 1001, FY 2022 NIH CURES Act innovation projects are funded in the amount of $496,000,000 to remain available until expended. | |||||
| 1120 | BA: Disc: Approps transferred to other accounts | Line added | -$38,630,000.00 | See footnotes below | ||
| Footnotes for line 1120 (Current): | B3: Pursuant to P. L. 116-260, P.L. 117-43, and P.L. 117-70, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. | |||||
| 1134 | BA: Disc: Appropriations precluded from obligation | -$247,934,800.00 | See footnotes below | |||
| Footnotes for line 1134 (Previous): | B3: Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05, and A-11 section 120.41. | |||||
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | -$113,958,500.00 | See footnotes below | -$307,370,000.00 | See footnotes below | |
| Footnotes for line 1151 (Previous): | B4: Pursuant to P. L. 116-260, P.L. 117-43, and P.L. 117-70, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. | |||||
| Footnotes for line 1151 (Current): | B4: Pursuant to P. L. 117-103, P.L. 117-43,P.L. 117-70, and PL 116-260, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. | |||||
| 1920 | Total budgetary resources avail (disc. and mand.) | $123,051,531.00 | $230,944,831.00 | |||
| 6011 | NIH Innovation, CURES Act | $123,051,531.00 | $230,944,831.00 | |||
| 6190 | Total budgetary resources available | $123,051,531.00 | See footnotes below | $230,944,831.00 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. A2: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. A3: Funds appropriated by PL 117-43 and extended by PL 117-70 were apportioned to this account by OMB Bulletin 21-05. In the event of an extension of that continuing resolution beyond February 18, 2021, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. | |||||
| Footnotes for line 6190 (Current): | A1: The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | |||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| B1 | Pursuant to P. L. 116-260 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. |
| B2 | Pursuant to PL 114-255, section 1001, FY 2022 NIH CURES Act innovation projects are funded in the amount of $496,000,000 to remain available until expended. |
| B3 | Pursuant to P. L. 116-260, P.L. 117-43, and P.L. 117-70, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. |
| B4 | Pursuant to P. L. 117-103, P.L. 117-43,P.L. 117-70, and PL 116-260, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this Excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | The total amount apportioned may be increased for recoveries of prior year obligations by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available. The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A3 | Funds appropriated by PL 117-43 and extended by PL 117-70 were apportioned to this account by OMB Bulletin 21-05. In the event of an extension of that continuing resolution beyond February 18, 2021, the amounts apportioned to this account for related activities shall be increased by the amount that automatic apportionment would have increased in the absence of this written apportionment. |
| B1 | Pursuant to P. L. 116-260 and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001, NIH CURES Act innovation projects funds remain available until expended. |
| B2 | Pursuant to PL 114-255, section 1001, FY 2021 NIH CURES Act innovation projects are funded in the amount of $404,000,000 to remain available until expended. |
| B3 | Amount on line 1134 has been adjusted pursuant to OMB Bulletin 21-05, and A-11 section 120.41. |
| B4 | Pursuant to P. L. 116-260, P.L. 117-43, and P.L. 117-70, and in accordance with the 21st Century CURES Act (P.L. 114-255) Section 1001. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.